Research Article
PDF Zotero Mendeley EndNote BibTex Cite

Evaluation of COVID-19 Patients with Chronic Kidney Disease

Year 2021, Volume 11, Issue 03, 152 - 158, 15.09.2021
https://doi.org/10.5799/jmid.993902

Abstract

Objectives: The present study seeks to provide insight into managing patients with chronic kidney disease (CKD) infected with COVID-19. Methods: Patients with COVID-19 with CKD were included in the study. The eligible patients were divided into four groups: 1) patients who were not on dialysis, 2) patients on maintenance dialysis, 3) patients who underwent dialysis following COVID-19, 4) patients with a history of a kidney transplant. After reviewing clinical charts, nursing records, laboratory findings, radiological reports, and other medical records of CKD patients with COVID-19 confirmed infection, clinical presentation, laboratory data, radiology findings, and results were extracted from documented medical records. The epidemiological, clinical, laboratory and outcome characteristics of the subgroups were evaluated and compared. Results: Seventy-eight patients were included into the study. Hypertension (50 cases, 72.5%), diabetes (44 cases, 63.8%), and Cardiovascular disease (26 cases, 38.2%) were the most common risk factors in the studied patients. Among all participants, 40 (52.6%) patients died. The most common symptom was dyspnea (56.6%), followed by dry cough (38.7%). Comparison of blood, inflammatory, biochemical, and clinical indices among the patients' groups show that LDH (P=0.022), AST (P=0.038), and ALT (P= 0.004) indices were significantly different between groups of patients. According to the results in Table 3, Unilateral ground-glass opacity (GGO) in the radiological findings of the Non-dialysis CKD group was significantly (P=0.50) higher than the other groups. Conclusion: It can be concluded that CKD is one of the critical factors that can cause poor prognosis in COVID-19 patients. J Microbiol Infect Dis 2021; 11(3):152-158.

References

  • 1. Estola T. Coronaviruses, a new group of animal RNA viruses. Avian diseases. 1970; 14(2):330-6.
  • 2. Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91:264-6.
  • 3. Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. Jama. 2020;323(8):707-8.
  • 4. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2020. https://covid19.who.int/. Accessed July 20 2020.
  • 5. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5).
  • 6. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049-57.
  • 7. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine. 2020:1-8.
  • 8. Joanne M. Bargman, Karl L. Skorecki. Chronic Kidney Disease. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison's principles of internal medicine; 2018.p.2111-2121.
  • 9. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395(10225):709-33.
  • 10. Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. Journal of the American Society of Nephrology: JASN. 2020;31(7):1380-3.
  • 11. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International urology and nephrology. 2020;52(6):1193-4.
  • 12. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International. 2020;97(5):829-38.
  • 13. Jung HY, Lim JH, Kang SH, Kim SG, Lee YH, Lee J, et al. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea. J Clin Med 2020;9(6).
  • 14. World Health O. Clinical management of COVID-19: interim guidance, May 27 2020. Geneva: World Health Organization. 2020. https://apps.who.int/iris/handle/10665/332196. Accessed July 20 2020.
  • 15. Wang R, Liao C, He H, Hu C, Wei Z, Hong Z, et al. COVID-19 in Hemodialysis Patients: A Report of 5 Cases. Am J Kidney Dis. 2020;76(1):141-3.
  • 16. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K, et al. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. Am J Nephrol. 2020; 51(5):337-42.
  • 17. Akalin E, Azzi Y, Bartash R, et al. Covid-19 and Kidney Transplantation. New England Journal of Medicine. 2020;382(25):2475-2477.
  • 18. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129-33.
  • 19. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol. 2017;198(10):4046-53.
  • 20. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
  • 21. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. 22. Ahmed SB, Ramesh S. Sex hormones in women with kidney disease. Nephrol Dial Transplant. 2016;31(11):1787-95.
  • 23. Ajaimy M, Melamed ML. COVID-19 in Patients with Kidney Disease. Clin J Am Soc Nephrol. 2020;15(8):1087-9.
  • 24. Lang J, Katz R, Ix JH, et al. Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders. Nephrol Dial Transplant. 2018;33(6):986-92.
  • 25. Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med. 2020;38(9):1722-6.
  • 26. Haimovich AD, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, Schulz WL, Taylor RA. Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation. Ann Emerg Med. 2020;76(4):442-453.

Details

Primary Language English
Subjects Health Care Sciences and Services
Journal Section Research Article
Authors

Yasaman Sadat KESHMIRI This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Sina Khosravi MIRZAIE This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Shahnaz SALI This is me (Primary Author)
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Davood YADEGARYNIA This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Sara ABOLGHASEMI This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Shabnam TEHRANI This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Amir ZAMANI This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran


Mohamad Mehdi DERISI This is me
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Iran

Publication Date September 15, 2021
Published in Issue Year 2021, Volume 11, Issue 03

Cite

Bibtex @research article { jmid993902, journal = {Journal of Microbiology and Infectious Diseases}, issn = {2146-3158}, eissn = {2146-9369}, address = {}, publisher = {Sağlık Araştırmaları Derneği}, year = {2021}, volume = {11}, pages = {152 - 158}, doi = {10.5799/jmid.993902}, title = {Evaluation of COVID-19 Patients with Chronic Kidney Disease}, key = {cite}, author = {Keshmırı, Yasaman Sadat and Mırzaıe, Sina Khosravi and Salı, Shahnaz and Yadegarynıa, Davood and Abolghasemı, Sara and Tehranı, Shabnam and Zamanı, Amir and Derısı, Mohamad Mehdi} }
APA Keshmırı, Y. S. , Mırzaıe, S. K. , Salı, S. , Yadegarynıa, D. , Abolghasemı, S. , Tehranı, S. , Zamanı, A. & Derısı, M. M. (2021). Evaluation of COVID-19 Patients with Chronic Kidney Disease . Journal of Microbiology and Infectious Diseases , 11 (03) , 152-158 . DOI: 10.5799/jmid.993902
MLA Keshmırı, Y. S. , Mırzaıe, S. K. , Salı, S. , Yadegarynıa, D. , Abolghasemı, S. , Tehranı, S. , Zamanı, A. , Derısı, M. M. "Evaluation of COVID-19 Patients with Chronic Kidney Disease" . Journal of Microbiology and Infectious Diseases 11 (2021 ): 152-158 <https://dergipark.org.tr/en/pub/jmid/issue/64866/993902>
Chicago Keshmırı, Y. S. , Mırzaıe, S. K. , Salı, S. , Yadegarynıa, D. , Abolghasemı, S. , Tehranı, S. , Zamanı, A. , Derısı, M. M. "Evaluation of COVID-19 Patients with Chronic Kidney Disease". Journal of Microbiology and Infectious Diseases 11 (2021 ): 152-158
RIS TY - JOUR T1 - Evaluation of COVID-19 Patients with Chronic Kidney Disease AU - Yasaman Sadat Keshmırı , Sina Khosravi Mırzaıe , Shahnaz Salı , Davood Yadegarynıa , Sara Abolghasemı , Shabnam Tehranı , Amir Zamanı , Mohamad Mehdi Derısı Y1 - 2021 PY - 2021 N1 - doi: 10.5799/jmid.993902 DO - 10.5799/jmid.993902 T2 - Journal of Microbiology and Infectious Diseases JF - Journal JO - JOR SP - 152 EP - 158 VL - 11 IS - 03 SN - 2146-3158-2146-9369 M3 - doi: 10.5799/jmid.993902 UR - https://doi.org/10.5799/jmid.993902 Y2 - 2021 ER -
EndNote %0 Journal of Microbiology and Infectious Diseases Evaluation of COVID-19 Patients with Chronic Kidney Disease %A Yasaman Sadat Keshmırı , Sina Khosravi Mırzaıe , Shahnaz Salı , Davood Yadegarynıa , Sara Abolghasemı , Shabnam Tehranı , Amir Zamanı , Mohamad Mehdi Derısı %T Evaluation of COVID-19 Patients with Chronic Kidney Disease %D 2021 %J Journal of Microbiology and Infectious Diseases %P 2146-3158-2146-9369 %V 11 %N 03 %R doi: 10.5799/jmid.993902 %U 10.5799/jmid.993902
ISNAD Keshmırı, Yasaman Sadat , Mırzaıe, Sina Khosravi , Salı, Shahnaz , Yadegarynıa, Davood , Abolghasemı, Sara , Tehranı, Shabnam , Zamanı, Amir , Derısı, Mohamad Mehdi . "Evaluation of COVID-19 Patients with Chronic Kidney Disease". Journal of Microbiology and Infectious Diseases 11 / 03 (September 2021): 152-158 . https://doi.org/10.5799/jmid.993902
AMA Keshmırı Y. S. , Mırzaıe S. K. , Salı S. , Yadegarynıa D. , Abolghasemı S. , Tehranı S. , Zamanı A. , Derısı M. M. Evaluation of COVID-19 Patients with Chronic Kidney Disease. J Microbil Infect Dis. 2021; 11(03): 152-158.
Vancouver Keshmırı Y. S. , Mırzaıe S. K. , Salı S. , Yadegarynıa D. , Abolghasemı S. , Tehranı S. , Zamanı A. , Derısı M. M. Evaluation of COVID-19 Patients with Chronic Kidney Disease. Journal of Microbiology and Infectious Diseases. 2021; 11(03): 152-158.
IEEE Y. S. Keshmırı , S. K. Mırzaıe , S. Salı , D. Yadegarynıa , S. Abolghasemı , S. Tehranı , A. Zamanı and M. M. Derısı , "Evaluation of COVID-19 Patients with Chronic Kidney Disease", Journal of Microbiology and Infectious Diseases, vol. 11, no. 03, pp. 152-158, Sep. 2021, doi:10.5799/jmid.993902